Phreesia, Inc. (PHR) vs SOPHiA GENETICS SA (SOPH)
Phreesia, Inc. and SOPHiA GENETICS SA are both Health Information Services companies. SOPHiA GENETICS SA is the larger, with a market value of $703.2M against $620.7M — 1.1× the size. SOPHiA GENETICS SA has negative trailing earnings, so its P/E is not meaningful; Phreesia, Inc. trades at 59.7×. SOPHiA GENETICS SA grew revenue faster over the last twelve months: 23.7% against 12.9%. Phreesia, Inc. has the higher net margin (2.06% vs −93.9%) and the higher return on invested capital (1.74% vs −196.5%). Across the 18 metrics below, Phreesia, Inc. leads on 15 and SOPHiA GENETICS SA on 3.
Valuation
Profitability
| Metric | PHR | SOPH | Health Information Services median |
|---|---|---|---|
| Gross margin | 67.52% | 66.63% | 63.38% |
| Operating margin | 2.47% | (85.55%) | (8.35%) |
| Net margin | 2.06% | (93.86%) | (14.70%) |
| Free cash flow margin | 13.30% | (47.83%) | 0.58% |
| Return on equity | 3.12% | (101.22%) | (6.82%) |
| Return on assets | 1.98% | (43.02%) | (6.02%) |
| Return on invested capital | 1.74% | (196.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack